Päivitetty 29.10.2024
Päivitetty 29.10.2024
Aro, Jussi
Studies on the clinical efficacy and side effects of the palliative treatment of prostatic cancer, 1991
Bergius, Susanne
Health-related quality of life and survival outcomes in prostate cancer, 2021
Blom, Sami
Spatial characterisation of prostate cancer by multiplex immunohistochemistry and quantitative image analysis, 2019
Eerola, Hannaleena
Breast Cancer Families in Finland, 2001
Eineluoto, Juho
CHARACTERISTICS OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER DIAGNOSTICS AND ACTIVE SURVEILLANCE, 2020
Erickson, Andrew
In Search of Improved Outcome Prediction of Prostate Cancer – A Biological and Clinical Approach, 2018
Finne, Patrik
Development and validation of methods for detection of prostate cancer, 2000
Färkkilä, Niilo
Health-related quality of life and costs in breast, prostate and colorectal cancer: a special focus on colorectal cancer, 2020
Haapiainen, Reijo
Studies on prognostic factors in prostatic cancer, 1986
Hackman, Greetta
Eturauhassyövän aktiivinen hoito (Active treatment of prostate cancer), 2021
Heinävaara, Sirpa
Modelling survival of patients with multiple cancers, 2003
Hekim Can
hK2 and PSA: Functions and Targets for Treatment of Prostate Cancer, 2012
Hemminki, Otto
Cancer immunotherapy with a gene modified serotype 3 oncolytic virus, 2015
af Hällström, Taija
p53 and DNA damage checkpoint responses in the human prostate, 2007
Ikonen, Saana
The role of magnetic resonance imaging in the detection, local staging, and diagnosis of prostate cancer, 2001
Jäämaa, Sari
DNA damage recognition in the normal epithelium of human prostate and seminal vesicles, 2011
Kalalahti, Inari
Prostate biopsies and active surveillance: infectious complications and how to reduce them, 2022
Kilkkinen, Annamari
Serum enterolactone: determinants and associations with breast and prostate cancers, 2004
Lahdensuo, Kanerva
Diagnostic and predictive tools in localized prostate cancer: biopsies, magnetic-resonance imaging, and tissue markers, 2017
Leinonen, Jari
Various molecular forms of prostate specific antigen (PSA) in the diagnosis of prostate cancer, 1999
Lehtonen, Rainer
The Role of Fumarase (FH) in Tumorigenesis, 2006
Liikanen, Ilkka
Combining Oncolytic Immunotherapy with Conventional Cancer Treatments, 2015
Lintula Susanna
Detection of prostate specific mRNAs in circulation and in prostatic tissue, 2005
Mattsson, Johanna
Antiangiogenic and proteolytic activities of prostate-specific antigen, 2014
Mikkola, Arto
Primary Polyestradiol Phosphate versus Orchiectomy for Advanced Prostate Cancer. Studies on the Efficacy, Cardiovascular Complications and Prognostic Factors, 2008
Nokisalmi,Petri
Experimental adenovirus gene therapy for cancer patients with advanced tumors: Translational medicine from basic research to the patient’s bedside, 2013
Ovaska, Kristian
Computational methods for analyzing complex high-throughput data from cancers, 2014
Paavonen, Karri
Vascular Endothelial Growth Factors and the Bmx Tyrosine Kinase in the Regulation of Angiogenesis and Lymphangiogenesis, 2003
Parviainen, Suvi
Developing genetically engineered oncolytic viruses for cancer gene therapy, 2015
Pihlajamaa, Päivi
Molecular Mechanisms of Androgen Receptor Function in Vivo, 2014
Quintero, Ileana B
Physiological Functions of Prostatic Acid Phosphatase,2015
Rajecki, Maria
Oncolytic Adenoviruses with Radiation Therapy for Treatment of Prostate Cancer, 2011
Rannikko, Sakari
Carcinoma of the prostate: a clinical and hormone investigation, 1979
Saaed, Khalid
Functional Testing of Urological Cancer Models by RNAi and Drug Libraries, 2018
Sahu, Biswajyoti
Genome-wide Analysis of Androgen Receptor Function in Prostate Cancer, 2012
Salo, Jaakko
Endo-ultrasonography and computed tomography in staging bladder and prostatic cancers, 1986
Sandeman, Kevin
Building Blocks of Prostate Cancer Diagnostics, 2023
Santti, Henrikki
Molecular determinants of androgen action, 2004
Soininen, Leena
The health of Finnish Sami in light of mortality and cancer pattern, 2015
Ståhlberg, Kaarlo
Estramustine and its derivatives in potentiating radiotherapy of prostate cancer, 2011
Sugiyama, Nami
Cooperation of MT1-MMP and receptor tyrosine kinase signaling in cancer cell invasion, 2013
Taube, Taina
Tumour invasion to bone: histomorphometric analysis of the bone disease induced by myelomatosis, breast cancer and prostate cancer, 1994
Thompson, James
Molecular Mechanisms of Androgen Receptor Interactions, 2006
Torvinen, Saku
Health-Related Quality of Life and Costs in Prostate Cancer, 2019
Zhang, Wan-Ming
Purification, characterization and clinical evaluation of various molecular forms of prostate-specific antigen, 2000
Zhigang, Kang
Androgen receptor in transcriptional regulation and carcinogenesis, 2006
Zhu, Lei
Development of Novel Assays for Measuring Different Molecular Forms of Prostate Specific Antigen, 2009
Vasarainen, Hanna
Screening and active surveillance in prostatic cancer, 2014
Wu, Ping
Identification, characterisation and utility of prostate-specific antigen-binding peptides, 2004
Karppi, Jouni
Measurement of carotenoids and their role in lipid oxidation and cancer, 2011
Kuivalainen, Leena
Health related quality of life among men with prostate cancer in one-year follow-up time, 2004
Makkonen, Harri
Androgen receptor-mediated gene activation in prostate cancer cells, 2010
Poutiainen, Pekka
Principles of Targeting Sex Steroid Receptors in Cancer Drug Research & Development, 2013
Raatikainen, Sami
TWIST and oxidative stress related biomarkers in outcome prediction of prostate cancer patients treated with radical prostatectomy, 2016
Romppanen, Jarkko
Serum sialic acid in clinical diagnostics, 2003
Salonen, Arto
Intermittent versus continuous androgen deprivation in patients with advanced prostate cancer: the Finnprostate Study VII, 2013
Sutinen, Päivi
SUMOylation in the Regulation of Androgen Receptor and Pioneer Factor FOXA1 in Prostate Cancer Cells, 2015
Toropainen, Sari
PIAS1 in androgen-regulated gene programs in prostate and brest cancer cells, 2016
Vesalainen, Satu
Prognostic factors in prostatic adenocarcinoma assessed by cytometric and histological methods, 1995
Vuolukka, Kristiina
Targeted Radiotherapy in Postate Cancer, 2021
Giannareas, Nikolaos
Discovery on somatic-germline interplay implicating prostate cancer predisposition and progression, 2021
Hakalahti, Leena
Generation and processing of monoclonal antibodies for applications in the diagnosis of prostatic cancer, 1993
Hammond, Geoffrey
Endocrinological factors and trace metals in normal and abnormal growth of the human prostate, 1978
Heikkilä, Vesa-Pekka
Härkönen, Päivi
17beta-hydroxysteroid dehydrogenases/17-ketosteroid reductases (17HSD/KSR) in prostatic cancer, 2005
Elo, Jussi
Genomic aberrations in prostate cancer: androgen receptor mutations and loss of heterozygosity at chromosome region 16q, 1998
Lukkarinen, Olavi
Serum steroid and pituitary hormones in prostatic carcinoma and hyperplasia: with special reference to the effect of treatment, 1981
Patrikainen, Lila
Prostatic gene expression: probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes, 2004
Perälä-Heape, Maritta
Radioimmunodetection of prostatic carcinoma with monoclonal antibodies: biodistribution of labelled monoclonal antibodies and their fragmets in a mouse model, 1991
Tonttila, Panu
Multiparametric magnetic resonance imaging for the detection and characterisation of prostate cancer, 2020
Vaarala Markku
Differential gene expression in prostate cancer. Identification of genes expressed in prostate cancer, androgen-dependent and androgen-independent LNCaP cell lines, and characterization of TMPRSS2 expression, 2000
Vihko, Pirkko
Human prostatic acid phosphatase and its radioimmunoassay, 1978
Virkkunen, Pirjo
Human prostatic acid phosphatase: cDNA-derived primary structure, characterization and chromosomal localizationof the gene, and restriction fragment length polymorphism at the gene Locus, 1993
Ahonen, Merja
Vitamin D in human ovarian and prostate cancer, 2002
Eerola, Sini
The role of PIM kinases in prostate cancer – promoting and inhibiting factors, 2022
Fischer, Daniel
On Statistical Methods in Prostate Cancer Genomics, 2017
Guo, Johannes
Finnish national job-exposure matrix (FINJEM) in register-based cancer research, 2005
Haapiainen, Henry
Evaluation of
three-dimensional laparoscopic prostatectomy in the treatment of
prostate cancer, 2024
Harju, Eeva
Health-related quality of life and marital relationship of patients with prostate cancer and their spouses, 2018
Hautamäki-Lamminen, Katja
Seksuaalisuuden muutokset syöpään sairastuessa – tiedontarpeet ja tiedonsaanti, 2012
Helin, Henrik
Digital Histopathology of Cancer, 2022
Hervonen, Petteri
Chemotherapy for Castration Resistant Metastatic Prostate Cancer, 2014
Hyytinen, Eija-Riitta
Molecular cytogenetics of prostate cancer: technology development and analysis of tumor progression, 1996
Jalava, Sanni
The role of 8q amplification and microRNAs in prostate cancer, 2012
Joentausta, Roni
Prostate cancer death, progression of prostate cancer, and erectile
dysfunction after radical prostatectomy among patients with statin
and metformin use, 2024
Kaapu, Kalle
Antiarrythmic Drugs and Cancer in Finnish Men: An epidemiological study on prostate cancer risk, survival and overall cancer mortality, 2019
Kartasalo, Kimmo
Machine learning and 3D-reconstruction methods for computational pathology, 2021
Kilpeläinen, Tuomas
Population- Based Screening for Prostate Cancer-Weighing up the Beneficial and Adverse Effects of Screening, 2013
Koivisto, Pasi
Androgen receptor gene amplification in hormone-refractory prostate cancer, 1997
Kylmälä, Timo
Prostate cancer and bone metastases: the effect of clodronate, 1997
Laitinen, Sari
Prostate cancer: from molecular genetics to prognostic markers, 2008
Laitinen, Virpi
Genetic Risk Factors for Hereditary Prostate Cancer in Finland, 2016
Lehmusvaara, Saara
Traditional and Novel Treatments for Prostate Cancer – Discoveries at the molecular level, 2012
Linja, Marika
Alterations in androgen receptor, estrogen receptors and their coregulatory genes in prostate cancer, 2003
Lou, Yan-Ru
Vitamin D<sub>3</sub> metabolism in normal and malignant human prostate cells, 2005
Matikainen, Mika
Genetic epidemiology of hereditary prostate cancer in Finland, 2001
Mattila, Henna
Hereditary prostate cancer in Finland: from genetic linkage to susceptibility genes, 2009
Mononen, Nina
Polymorphisms in genes associated with androgen biosynthesis and metabolism as risk factors for human prostate cancer, 2005
Murtola, Teemu
Prostate cancer incidence among men using statins, finasteride or antidiabetic drugs, 2009
Mäkinen, Tuukka
The Finnish Population-Based Prostate Cancer Screening Trial. A clinical perspective, 2008
Määttänen, Liisa
Performans of the Finnish Prostate Cancer Screening Trial Based on Process Indicators, 2007
Nazarova, Nadezda
Regulation of growth factor signaling by vitamin D in human prostate cancer cells, 2006
Nummenmaa, Juho
Näyttöön perustuvat hoitosuositukset ja yleislääkärin työ, 2007
Nupponen Nina N
Amplification of EIF3S3 in breast and prostate cancer, 1999
Nurminen, Riikka
Genetic Susceptibility Factors for Prostate Cancer at Chromosomal Region 11q13.5, 2016
Oksanen, Hanna
Modelling the survival of prostate cancer patients, 1998
Pakkanen, Sanna
Profiling of High-risk Prostate Cancer Families in Finland, 2010
Palmberg, Christian
Androgen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor gene amplification, 2000
Porkka, Kati
Differentially expressed genes in prostate cancer, 2003
Qiao, Shengjun
Fatty Acid Metabolism, Vitamin D3 and Prostate Cancer, 2006
Rantapero, Tommi
Developing a Framework for Analysis of Next-Generation Sequencing Data in Cancer Genetics and Epigenetics, 2020
Rauhala, Hanna
DNA hypermethylation in prostate cancer, 2009
Roine, Antti
Novel Spectrometric Methods in Detection of Prostate Cancer and Urinary Tract Infection, 2014
Rökman, Annika
In search of high-penetrant hereditary prostate cancer susceptibility genes in Finland, 2004
Santala, Eerik
The association between antihypertensive drug use and risk of cancer death in Finland, 2023
Saramäki, Outi
Gene copy number alterations in prostate cancer, 2006
Savinainen, Kimmo
Amplification and overexpression of ERBB2, uPA, TRPS1, EIF353 and MYC genes in prostatic cancer, 2006
Scaravilli, Mauro
Identification of 1p21-22 Amplification in Bladder Cancer and Expression of non-coding RNAs in Prostate Cancer, 2016
Seppälä, Eija
Heterogeneity in genetic susceptibility to prostate cancer, 2006
Siltanen, Sanna
Contribution of the ARLTS1 Gene to Prostate Cancer Susceptibility, 2013
Sunny, Lizzy
Prostate Cancer – An Epidemiological Study in India, 2005
Sormunen, Jorma
Physical Activity and Incidence of Cancer with Special Emphasis on Colorectal and Prostate Cancers in Men, 2018
Tabaro, Francesco
Analysis of Chromatin and Proteins in Cancer, 2020
Talvitie, Anna-Maija
Quality of Life After Prostate Cancer Treatment, 2024
Tolonen, Teemu
Molecular biomarkers and histopathological parameters in prostate cancer diagnostics and prognostics, 2011
Urbanucci, Alfonso
Overexpression of Androgen Receptor in Prostate Cancer, 2012
Veitonmäki, Thea
Non-steroidal anti-inflammatory drugs and cancer in Finnish men. An epidemiologic study on prostate cancer risk, survival and overall cancer mortality, 2016
Visakorpi, Tapio
Cell proliferation rate in prostatic carcinoma: prognostic value and relation to epidermal growth factor receptor and p53 expression, 1992
Waltering, Kati
Androgen receptor signalling pathway in prostate cancer, 2010
Wang, Jing-Huan
Vitamin D, Lipid Metabolism and Prostate Cancer, 2009
Ahonen, Tommi
Characterization of signal transducer and activator of transcription 5 (Stat5)-dependent survival of prostate cancer cells, 2005
Anttinen, Mikael
Novel imaging and image-guided therapy of prostate cancer, 2021
Björkman, Mari
Identification of Epigenetic Targets in Prostate Cancer for Therapeutic Development, 2013
Buhmeida, Abdelbaset
Application of image analytic DNA cytometry and morphometry in prostatic fine needle aspiration biopsies, 2002
Elo, Teresa
The Effects of Fibroblast Growth Factor 8b on Reproductive Organs and Prostate Tumorigenesis, 2013
Huhtinen, Petri
Lanthanide Nanoparticles – Preparation and New Applications in Bioaffinity Assays, 2006
Jambor, Ivan
Towards improved characterization of prostate cancer using magnetic resonance imaging and positron emission tomography, 2017
Ketola, Kirsi
Chemical Biology Screen for Prostate Cancer Therapeutics, 2011
Knaapila, Juha
Challenges in diagnostics of Prostate cancer, 2020
Knuuttila, Matias
Intratumoral androgen biosynthesis in prostate cancer: Evidence from preclinical models and clinical specimens, 2017
Korpela, Jaana
First-line chemotherapy with anthracycline and taxane combination in metastatic breast cancer. Detection of bone metastases with TRACP 5b, 2011
Kuisma, Anna
Multimodality Imaging in Prostate Cancer, 2023
Malaspina, Simona
Prostate-specific membrane antigen as a target for prostate cancer PET imaging, 2023
Mialon, Antoine
Role and Function of c-Jun Protein Complex in Cancer Cell Behavior, 2009
Mirtti, Tuomas
Tissue Markers and Molecular Mechanisms in Pathogenesis and Clinical Progression of Prostate Cancer, 2006
Mäkelä, Pietari
MRI Findings After
Transurethral Ultrasound Ablation of Prostate, 2024
Nevalainen, Marja Tuuli
Prolactin regulation of rat and human prostate, 1997
Niemelä, Pauliina
Circulating Forms of Free Prostate-Specific Antigen and Their Use in Prostate Cancer Diagnostics, 2002
Oksala, Riikka
ANDROGEN SIGNALING AXIS AS DRUG TARGET IN CASTRATION-RESISTANT PROSTATE CANCER: Preclinical development of novel treatments and models, 2018
Pellinen, Teijo
β1 integrin regulation, 2009
Pelo, Camilla
Collagen Binding Integrins and Cancer Testis Antigens in Prostate Cancer and Melanoma, 2016
Peltola, Katriina
Signaling in cancer: pim-1 kinase and its partners, 2004
Peltola, Mari
Free Prostate-specific Antigen Forms and Kallikrein-related Peptidase 2: Tools for Prostate Cancer Diagnostics, 2012
Pylkkänen, Liisa
Neonatally estrogenized mouse as a model for the study of prostatic carcinogenesis, 1992
Salmenperä, Liisa
Complementary and alternative medicine: attitudes of cancer patients, nurses and physicians, the use of complementary and alternative medicine by cancer patients, 2005
Santio, Niina
PIM signaling in cancer – regulation of cell motility and metabolism), 2016
Seppälä, Jan
The Possibilities and Dosimetric Limitations of MLC-Based Intensity-Modulated Radiotherapy Delivery and Optimization Techniques, 2012
Seikkula, Heikki
Studies on prostate-specific antigen and prostate cancer epidemiology, 2017
Suominen, Mari
Dual inhibition of the vicious cycle and tumor growth in breast and prostate cancer bone metastasis – evaluation of various therapeutic approaches in experimental mouse models, 2018
Tuomela, Johanna
Orthotopic PC-3 Tumor Xenografts in Studies on Prostate Cancer Growth and Metastasis, 2010
Tuomi, Saara
The Integrin Tail: A Tale of Cell Motility and Division, 2010
Vainio, Paula
High-Throughput Screening for Novel Prostate Cancer Drug Targets-Getting Personal, 2011
Valta, Maija
Fibroblast Growth Factor 8 in the Progression of Hormonal Cancer; Cancer-associated Bone Formation and Bone Metastasis, 2008
Valve, Eeva
Activation of FGF-8 in hormonal cancer: with special reference to murine breast cancer cells and human prostate and ovarian cancer, 2000
Virtakoivu, Reetta
Vitamin D<sub>3</sub> metabolism in normal and malignant human prostate cells, 2015
Virtanen, Sanna
Bisphosphonate Inhibition of Prostate Cancer Cell Invasion, Migration and Cytoskeletal Organization, 2010
Ylikoski, Alice
Quantitative detection of prostate-specific antigen and human glandular kallikrein 2 mRNAs, 2001
Yu, Lan
Role of fibroblast growth factors and their receptors in prostate cancer, 2016
HY | ISY | OY | TaY | TY | Yhteensä | |
1970-luku | 1 | 2 | 3 | |||
1980-luku | 2 | 1 | 3 | |||
1990-luku | 3 | 1 | 4 | 6 | 2 | 16 |
2000-luku | 16 | 2 | 3 | 23 | 12 | 56 |
2010-luku | 21 | 7 | 1 | 19 | 19 | 67 |
2020-luku | 6 | 1 | 2 | 9 | 4 | 19 |
Yhteensä | 49 | 11 | 13 | 57 | 38 | 168 |
PSA on eturauhassyövän diagnostiikassa ja seurannassa käytettävä merkkiaine. Nykyään eturauhassyöpäepäily herää useimmiten koholla olevan PSA-arvon takia, ei oireiden. Vähäisistäkin virtsaamisoireista kärsiville yli 50-vuotiaille miehille on tehtävä PSA-määritys ja muut asianmukaiset tutkimukset mahdollisen eturauhassyövän toteamiseksi.
Paikallinen ja parannettavissa oleva eturauhassyöpä ei juurikaan oireile, vaan oireet johtuvat samanaikaisesti esiintyvästä eturauhasen hyvänlaatuisesta liikakasvusta. Eturauhassyövän edetessä tauti voi aiheuttaa paikallisia oireita, jotka ovat samanlaisia kuin hyvänlaatuisessa liikakasvussa, mm. virtsavaivat.
Pohjoismaiseen kaksosaineistoon perustuvan tutkimuksen perusteella eturauhassyövän kehittymisessä perimällä on suurin merkitys tutkituista syövistä. Jos miehen isällä tai veljellä on todettu eturauhassyöpä, hänen riskinsä sairastua on kaksinkertainen verrattuna miehiin, joiden suvussa eturauhassyöpää ei ole esiintynyt.